| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/01/1999 | CA2300197A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926145A1 Napthalene compounds, method for their preparation and pharmaceutical compositions containing them |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925297A1 Endothelin receptor antagonists |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925286A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0925062A1 Therapeutic utilities of verapamil enantiomers |
| 06/30/1999 | EP0924985A1 Method for inhibiting the expression of fas |
| 06/30/1999 | EP0701606A4 Method of enhancing thrombolysis |
| 06/30/1999 | EP0526540B1 Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke |
| 06/30/1999 | CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/30/1999 | CN1221414A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 06/30/1999 | CN1221410A Novel substituted 2,4-thiazolidine diketone derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221339A Use of inhibitors of cellular Na+/H+ exchanger (NHE) for preparing medicament for normalizing serum lipids |
| 06/30/1999 | CN1220892A Formula of Chinese medicine preparation for treating heart disease and preparation method thereof |
| 06/30/1999 | CN1043893C Pharmaceuticals |
| 06/30/1999 | CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/29/1999 | US5917053 Inhibiting gaba release from neurons |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031126A1 Cyclopeptide derivatives with integrin inhibitor properties |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031100A1 Novel bispidine antiarrhythmic compounds |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031092A1 Benzamine derivatives |
| 06/24/1999 | WO1999031085A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999031068A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031059A1 Potassium channel openers |
| 06/24/1999 | WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031049A1 Neuroprotective agents |
| 06/24/1999 | WO1999030764A1 Systems and methods for local delivery of an agent |
| 06/24/1999 | WO1999030741A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 06/24/1999 | WO1999030732A1 Gamma-conopeptides |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030706A1 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
| 06/24/1999 | WO1999030704A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | WO1999030699A1 Modulators of cysteine protease |
| 06/24/1999 | WO1999030696A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | WO1999030687A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | DE19756036A1 New indole amide derivatives |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2315370A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315079A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/24/1999 | CA2314968A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | CA2314948A1 Potassium channel openers |
| 06/24/1999 | CA2314686A1 Gamma-conopeptides |
| 06/24/1999 | CA2314490A1 Novel bispidine antiarrhythmic compounds |
| 06/24/1999 | CA2313651A1 Benzamine derivatives |
| 06/24/1999 | CA2313212A1 Modulators of cysteine protease |
| 06/24/1999 | CA2311932A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | CA2304612A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | CA2299397A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 06/24/1999 | CA2280705A1 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositionscomprising the same |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/23/1999 | EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/23/1999 | EP0923569A1 Butyric acid matrix metalloproteinase inhibitors |
| 06/23/1999 | EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923553A1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 06/23/1999 | EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 06/23/1999 | EP0923547A1 Bidentate metalloprotease inhibitors |
| 06/23/1999 | EP0923543A1 Potassium channel inhibitors |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923379A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 06/23/1999 | EP0923373A1 Il-8 receptor antagonists |
| 06/23/1999 | EP0752861A4 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 06/23/1999 | EP0502117B1 Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone |
| 06/23/1999 | CN1220660A Alkyloxyamino substituted fluorenones and their use as protein kinase cinhibitors |
| 06/23/1999 | CN1220658A Galcium receptor-active compound |
| 06/23/1999 | CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof |
| 06/23/1999 | CN1220165A Kelp product and its making method and use |
| 06/23/1999 | CN1043765C Pyrroloquinolinone derivatives, its preparing method, its intermediate and drug composition containing the same |
| 06/23/1999 | CN1043764C Bicycle carboxamides as 5-HT1A antagonists |
| 06/23/1999 | CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition |
| 06/22/1999 | US5914338 Heterocyclic compounds and their preparation and use |
| 06/22/1999 | US5914329 Dimesylate salts of neuropeptide Y ligands |
| 06/22/1999 | US5914324 6-Hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |